CLDI - Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering
Story updates
01:11:48 PM UTC
SquawkNews
Calidi Biotherapeutics priced a registered direct sale of 1,025,640 shares at $1.17 per share for gross proceeds of approximately $1.2M, expected to close on or about Sept. 18, 2026, subject to customary conditions.Material DetailsContext by AI AnalystThis is another small-cap biotech financing typ…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.